InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Krempa David, Chief Business Officer. Director active across 1 company, notably Eton Pharmaceuticals, Inc.. Cumulatively, 16 filings have been published. Breakdown: 0 buy · 7 sells. Total volume traded: €4.4m. Activity tracked since 12 June 2025. The latest transaction was disclosed on 24 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Krempa David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
25,000 股@ US$7.31Common StockSEC:0001437749-26-028846:0
25,000 股@ US$65.07Common StockSEC:0001437749-26-028846:1
10,000 股Common StockSEC:0001437749-26-023440:0
519 股@ US$35.000.0010% mcap0.5% 占其流量Common StockSEC:0001437749-26-018628:3
19,679 股@ US$31.47390.034% mcap16.7% 占其流量Common StockSEC:0001437749-26-018628:9
30,591 股@ US$3.580.0061% mcap3.0% 占其流量Common StockSEC:0001437749-26-018628:0
32,963 股@ US$33.22080.061% mcap29.6% 占其流量Common StockSEC:0001437749-26-018628:1
9,315 股@ US$33.88020.018% mcap8.5% 占其流量Common StockSEC:0001437749-26-018628:2
25,000 股@ US$1.380.0019% mcap0.9% 占其流量Common StockSEC:0001437749-26-018628:4
12,524 股@ US$1.370.0010% mcap0.5% 占其流量Common StockSEC:0001437749-26-018628:5
37,524 股@ US$31.49270.065% mcap31.9% 占其流量Common StockSEC:0001437749-26-018628:6
12,476 股@ US$1.370.0009% mcap0.5% 占其流量Common StockSEC:0001437749-26-018628:7
7,203 股@ US$3.580.0014% mcap0.7% 占其流量Common StockSEC:0001437749-26-018628:8
1,942 股@ US$15.620.0017% mcap11.2% 占其流量Common StockSEC:0001437749-26-001288:0
6,264 股@ US$17.000.0058% mcap38.8% 占其流量Common StockSEC:0001437749-25-037745:0
16,977 股@ US$14.926.6% 占其流量Common StockSEC:0001437749-25-020518:0
16 条申报中的 16 条
About Krempa David
Krempa David is Chief Business Officer at Eton Pharmaceuticals, Inc. He has 14 filings in total, and across the recent filings tracked, they cover the period from 2025-06-16 to 2026-07-13, with EUR 0 in purchases and EUR 2995614 in sales, the most frequent transaction nature being Levée d'options.
